Exosome RNA Exosome RNA Research & Industry News
Extracellular vesicles, often called exosomes, carry many different surface proteins that help them find target cells and influence how those cells respond. These surface molecules are central to how vesicles work, but studying them has been difficult because natural vesicles are highly diverse and hard to control experimentally.
Researchers at the University of California, Davis developed a new way to tackle this challenge using a fully cell-free system. Instead of relying on living cells to produce vesicles, the team built a synthetic platform that allows individual extracellular vesicle surface protein domains to be added, one by one, onto artificial nanovesicles. This approach makes it possible to study how specific surface proteins affect vesicle behavior in a controlled and scalable way.
The platform, called VESSEL, uses a bacterial membrane protein as an anchor to insert selected surface protein domains into artificial vesicles. The researchers chose these protein domains based on proteomics data from placental mesenchymal stem cell vesicles, ensuring biological relevance. Using this system, they generated dozens of well-defined vesicle mimetics and analyzed them with high-resolution techniques such as single-vesicle flow cytometry and super-resolution imaging.
By testing how these engineered vesicles interact with cells, the team showed that certain surface proteins strongly influence cellular uptake. Some proteins promoted efficient entry into human cells, while others had little effect. Notably, the work identified proteins like CADM1 and NPTN as potent drivers of vesicle uptake. When several of these proteins were tested in a neuronal model, some also enhanced neurite growth, pointing to potential applications in neuroprotection.
Overall, this work provides a powerful new toolkit for dissecting how extracellular vesicle surface proteins control cell targeting and function. By reducing vesicles to their essential components, the VESSEL platform helps turn complex biological messengers into well-defined tools for both basic research and therapeutic design.
